Revlimid vs Opdivo
Side-by-side drug price comparison from Medicare Part D data
Verdict
Revlimid costs 19% less per claim than Opdivo ($12786.00 vs $15821.00). Opdivo has a generic alternative available. Total Medicare spending: Revlimid at $7.8B vs Opdivo at $5.1B.
| Metric | Revlimid | Opdivo |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $12,786* | $15,821 |
| Total Medicare Spending Total Medicare Part D spending on this drug | $7.8B | $5.1B |
| Total Claims | 612,000 | 324,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | -3.4%* | 15.8% |
| Generic Available | No | Yes |
| Condition | Cancer | Cancer |
| Total Beneficiaries | 58,000 | 66,000 |
Revlimid costs 19% less per claim than Opdivo ($12786.00 vs $15821.00). Opdivo has a generic alternative available. Total Medicare spending: Revlimid at $7.8B vs Opdivo at $5.1B.